Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1944 1
1962 1
1970 1
1971 1
1973 1
1974 3
1975 11
1976 8
1977 14
1978 10
1979 19
1980 7
1981 22
1982 33
1983 27
1984 44
1985 47
1986 60
1987 44
1988 63
1989 70
1990 90
1991 95
1992 125
1993 147
1994 170
1995 251
1996 312
1997 407
1998 513
1999 676
2000 877
2001 1002
2002 1203
2003 1271
2004 1525
2005 1608
2006 1628
2007 1818
2008 1917
2009 2197
2010 2284
2011 2486
2012 2745
2013 2807
2014 2802
2015 2747
2016 1525
2017 1027
2018 1339
2019 1374
2020 1458
2021 1397
2022 1385
2023 1116
2024 205

Text availability

Article attribute

Article type

Publication date

Search Results

39,847 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for factor a t
Search for Fatorma T instead (3 results)
Direct and Indirect Modulation of T Cells by VEGF-A Counteracted by Anti-Angiogenic Treatment.
Bourhis M, Palle J, Galy-Fauroux I, Terme M. Bourhis M, et al. Front Immunol. 2021 Mar 29;12:616837. doi: 10.3389/fimmu.2021.616837. eCollection 2021. Front Immunol. 2021. PMID: 33854498 Free PMC article. Review.
Vascular endothelial growth factor A is known to play a central role in tumor angiogenesis. Several studies showed that VEGF-A is also an immunosuppressive factor. In tumor-bearing hosts, VEGF-A can modulate immune cells (DC, MDSC, TAM) to induce the accumulation of …
Vascular endothelial growth factor A is known to play a central role in tumor angiogenesis. Several studies showed that VEGF-A …
Vascular endothelial growth factor-A: a multifunctional molecular player in diabetic retinopathy.
Zhang X, Bao S, Hambly BD, Gillies MC. Zhang X, et al. Int J Biochem Cell Biol. 2009 Dec;41(12):2368-71. doi: 10.1016/j.biocel.2009.07.011. Epub 2009 Jul 29. Int J Biochem Cell Biol. 2009. PMID: 19646547 Review.
Vascular endothelial growth factor-A (VEGF-A), first described as "vascular permeability factor", is a critical molecule in the pathogenesis of diabetic retinopathy at several levels. ...
Vascular endothelial growth factor-A (VEGF-A), first described as "vascular permeability factor", is a critical molecule in th …
Vascular endothelial growth factor-A as a promising therapeutic target for the management of psoriasis.
Luengas-Martinez A, Hardman-Smart J, Paus R, Young HS. Luengas-Martinez A, et al. Exp Dermatol. 2020 Aug;29(8):687-698. doi: 10.1111/exd.14151. Exp Dermatol. 2020. PMID: 32654325
Vascular endothelial growth factor-A (VEGF-A), the main angiogenic mediator, plays a critical role in the pathogenesis of several inflammatory immune-mediated diseases, including psoriasis. ...
Vascular endothelial growth factor-A (VEGF-A), the main angiogenic mediator, plays a critical role in the pathogenesis of seve …
MicroRNA-31 inhibits traumatic brain injury-triggered neuronal cell apoptosis by regulating hypoxia-inducible factor-1A/vascular endothelial growth factor A axis.
Qian Y, Li X, Fan R, Li Q, Zhang Y, He X, Yang W, Sun W, Lv S. Qian Y, et al. Neuroreport. 2022 Jan 5;33(1):1-12. doi: 10.1097/WNR.0000000000001741. Neuroreport. 2022. PMID: 34874324
Quantitative reverse transcription-PCR was used to detect the regulation of traumatic neuron injury or hypoxia-inducible factor-1A overexpression on vascular endothelial growth factor A level. The effects of hypoxia-inducible factor-1A or vascular endothelial growth …
Quantitative reverse transcription-PCR was used to detect the regulation of traumatic neuron injury or hypoxia-inducible factor-1A overexpre …
Vascular Endothelial Growth Factor A c.*237C>T polymorphism is associated with bevacizumab efficacy and related hypertension in metastatic colorectal cancer.
Sibertin-Blanc C, Mancini J, Fabre A, Lagarde A, Del Grande J, Levy N, Seitz JF, Olschwang S, Dahan L. Sibertin-Blanc C, et al. Dig Liver Dis. 2015 Apr;47(4):331-7. doi: 10.1016/j.dld.2014.12.013. Epub 2014 Dec 30. Dig Liver Dis. 2015. PMID: 25617075
METHODS: We retrospectively included patients who were treated with bevacizumab-based chemotherapy for metastatic colorectal cancer, and for whom a deoxyribonucleic acid sample was available. Ten polymorphisms in Vascular Endothelial Growth Factor-A, his receptors a …
METHODS: We retrospectively included patients who were treated with bevacizumab-based chemotherapy for metastatic colorectal cancer, and for …
Monoclonal antibodies neutralizing alpha-hemolysin, bicomponent leukocidins, and clumping factor A protected against Staphylococcus aureus-induced acute circulatory failure in a mechanically ventilated rabbit model of hyperdynamic septic shock.
Nguyen NTQ, Doan TNM, Sato K, Tkaczyk C, Sellman BR, Diep BA. Nguyen NTQ, et al. Front Immunol. 2023 Sep 15;14:1260627. doi: 10.3389/fimmu.2023.1260627. eCollection 2023. Front Immunol. 2023. PMID: 37781371 Free PMC article.
To demonstrate the potential utility of this hyperdynamic septic shock model for preclinical drug development, rabbits were randomized for prophylaxis with anti-Hla/Luk/ClfA monoclonal antibody combination that neutralizes alpha-hemolysin (Hla), the bicomponent pore-forming leuko …
To demonstrate the potential utility of this hyperdynamic septic shock model for preclinical drug development, rabbits were randomized for p …
An integrative model for vascular endothelial growth factor A as a tumour biomarker.
Latham AM, Molina-París C, Homer-Vanniasinkam S, Ponnambalam S. Latham AM, et al. Integr Biol (Camb). 2010 Sep;2(9):397-407. doi: 10.1039/c0ib00008f. Epub 2010 Aug 20. Integr Biol (Camb). 2010. PMID: 20725676 Review.
Vascular endothelial growth factor A (VEGF-A) and its cognate receptors are central to the regulation of angiogenesis in both physiological and pathological states. ...
Vascular endothelial growth factor A (VEGF-A) and its cognate receptors are central to the regulation of angiogenesis in both …
39,847 results
You have reached the last available page of results. Please see the User Guide for more information.